Shlomo Ben-Haim
Angel Investor
London, United Kingdom
Shlomo Ben-Haim is a Series A investor in London focused on Health Care and Credit. Shlomo Ben-Haim is based out of London, England and is the Founder and Chairman of Cara Medical. Shlomo previously worked at Spectrum Dynamics as a Founder.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Shlomo Ben-Haim invests in
Stages Shlomo Ben-Haim invests in
Countries Shlomo Ben-Haim invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $2.8M–$6.5M
- Series A
- $5.1M–$40M
Investment Focus
Industry
- Health Care 2 (40%)
- Credit 1 (20%)
- FinTech 1 (20%)
- Finance 1 (20%)
- Fitness 1 (20%)
Stage
- Series A 3 (60%)
- Seed 2 (40%)
Country
- India 2 (40%)
- United States 2 (40%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Earli is a developer of cancer treatment devices designed to search for natural biomarkers. The company's mission is to make cancer a benign experience. Cancers are detected early when they are homogeneous; and then located early, so they can be treated when the chances of survival are multiple times higher. Rather than rely on biomarkers thatcancer may - or often may not - naturally provide, Earli's technology forces cancer cells to make a synthetic, non-human biomarker using a novel gene therapy approach called Synthetic Biopsy. The early cancer is then visible in a PET scanner. The same platform is also usable for therapeutics. | $40M / Series A / Jan 12, 2021 | ||
| Kaleidofin is a fintech platform that provides complete financial solutions for excluded individuals and households. The platform propels under-banked customers towards meeting their real life goals by providing intuitive and tailored financial solutions. Their solutions take into account the financial roadblocks and vulnerability that thesesegments, such as volatile income streams and limited understanding of the fine print in financial products.Kaleidofin creates individual profiles of households based on several sources and uses that information to tailor its services for each customer. It also provides curated, goal-based financial solutions to people in the underbanked segments. It will leverage the full India stack, existing networks, analytics, structuring, and user-centered design to drive outcomes for customers, in the processKaleidofin was founded in 2017 and is headquartered in Chennai, Tamil Nadu, India. | $5.1M / Series A / Dec 19, 2019 | ||
| 100Plus is the fastest-growing remote patient monitoring platform empowering doctors to manage their chronic patients remotely and proactively engage them to avoid expensive, episodic care and drive a higher quality of life. When a Medicare patient receives a 100Plus medical device, it’s at no cost to the patient or practice, fully configured, andready to use out of the box — no smartphone, app, Bluetooth, or WiFi required. Reduce episodic care and improve patient care by continuously monitoring high-risk seniors in your population. | $6.5M / Seed / May 02, 2018 | ||
| Kaleidofin is a fintech platform that provides complete financial solutions for excluded individuals and households. The platform propels under-banked customers towards meeting their real life goals by providing intuitive and tailored financial solutions. Their solutions take into account the financial roadblocks and vulnerability that thesesegments, such as volatile income streams and limited understanding of the fine print in financial products.Kaleidofin creates individual profiles of households based on several sources and uses that information to tailor its services for each customer. It also provides curated, goal-based financial solutions to people in the underbanked segments. It will leverage the full India stack, existing networks, analytics, structuring, and user-centered design to drive outcomes for customers, in the processKaleidofin was founded in 2017 and is headquartered in Chennai, Tamil Nadu, India. | $2.8M / Seed / Apr 09, 2018 | ||
| Kaleidofin Capital focuses on offering accessible loan solutions to the informal sector. | Series A |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Shlomo Ben-Haim invest in?
Shlomo Ben-Haim invests primarily in Health Care, Credit and FinTech startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Shlomo Ben-Haim invest in?
Shlomo Ben-Haim typically joins rounds of $2.8M–$6.5M at Seed and $5.1M–$40M at Series A. These are whole funding-round sizes, not Shlomo Ben-Haim's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Shlomo Ben-Haim took part in.
How do I contact Shlomo Ben-Haim?
Public channels for Shlomo Ben-Haim include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Shlomo Ben-Haim last invest?
The most recent investment recorded for Shlomo Ben-Haim closed in Jan 2021. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
